CA2637538A1 - Dar 1 (dermal acne remover) - Google Patents
Dar 1 (dermal acne remover) Download PDFInfo
- Publication number
- CA2637538A1 CA2637538A1 CA002637538A CA2637538A CA2637538A1 CA 2637538 A1 CA2637538 A1 CA 2637538A1 CA 002637538 A CA002637538 A CA 002637538A CA 2637538 A CA2637538 A CA 2637538A CA 2637538 A1 CA2637538 A1 CA 2637538A1
- Authority
- CA
- Canada
- Prior art keywords
- dar
- dermal
- acne
- acne remover
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 6
- 206010000496 acne Diseases 0.000 title claims abstract description 6
- 230000002500 effect on skin Effects 0.000 title 1
- 239000006071 cream Substances 0.000 claims abstract description 5
- 210000003491 skin Anatomy 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 206010061218 Inflammation Diseases 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000008439 repair process Effects 0.000 claims description 2
- 210000004927 skin cell Anatomy 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940088129 calcium pantothenate 10 mg Drugs 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- 229940088126 cupric oxide 2 mg Drugs 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229940068840 d-biotin Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 229940002880 ferrous fumarate 18 mg Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 229940064321 magnesium oxide 100 mg Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229940089784 niacinamide 20 mg Drugs 0.000 description 1
- LGQLOGILCSXPEA-UHFFFAOYSA-L nickel sulfate Chemical compound [Ni+2].[O-]S([O-])(=O)=O LGQLOGILCSXPEA-UHFFFAOYSA-L 0.000 description 1
- 229910000363 nickel(II) sulfate Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940089805 riboflavin 1.7 mg Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- CMZUMMUJMWNLFH-UHFFFAOYSA-N sodium metavanadate Chemical compound [Na+].[O-][V](=O)=O CMZUMMUJMWNLFH-UHFFFAOYSA-N 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229940056069 zinc oxide 15 mg Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention is a spot treatment cream used once a day that clears acne in one week or less.
Description
SPECIFICATIONS
[Para 2] The present invention relates to DAR 1. The invention is comprised of the following components:
(3) Zinc oxide cream - base cream 1/8 oz (4) Tea tree oil - kills bacteria and fungus that cause acne. 1 ml (5) Ibuprofen - Anti-inflammatory 400mg (6) Retinyl Acetate and Beta-Carotene - antioxidant 3500 IU
(7) Ascorbic Acid - antioxidant 60mg (8) dl-Alpha Tocopheryl Acetate - antioxidant 30 IU
(9) The following ingredients are to help rejeuvenate and heal the skin:
(10) Cholecalciferol 400 IU
(11) Phytonadione 25mcg (12) Thiamin Mononitrate 1.5mg (13) Riboflavin 1.7mg (14) Niacinamide 20mg (15) Pyridoxine Hydrochloride 2mg (16) Folic Acid 400mcg (17) Cyanocobalamin 6mcg (18) d-Biotin 30mcg (19) d-Calcium Pantothenate 10mg (20) Dicalcium Phosphate and calcium carbonate 162mg (21) Ferrous fumarate 18mg (22) Dicalcium Phosphate 109mg (23) Potassium Iodide 150mcg (24) Magnesium Oxide 100mg (25) Zinc Oxide 15mg (26) Sodium Selenate 20mcg (27) Cupric Oxide 2mg (28) Manganese Sulfate 2mg (29) Chromium Chloride 120mcg (30) Sodium Molybdate 75mcg (31) Potassium Chloride 72mg (32) Boron 150mcg (33) Nickel Sulfate 5mcg (34) Silicon Dioxide 2mg (35) Tin Chloride 10mcg (36) Sodium Metavanadate 10mcg (37) Lutein 250mcg (38) Lycopene 300mcg [Para 39] These components combined help kill bacteria and fungus that cause acne, help reduce oil production by the skin, reduce inflammation and repair underlying skin cells. Some of the ingredients can be omitted, or substituted with similar ingredients to achieve the same results.
[Para 40] The cream can also be used to treat inflammatory skin conditions, itching, scarring, scarring caused by acne, and discolorations of the skin.
[Para 2] The present invention relates to DAR 1. The invention is comprised of the following components:
(3) Zinc oxide cream - base cream 1/8 oz (4) Tea tree oil - kills bacteria and fungus that cause acne. 1 ml (5) Ibuprofen - Anti-inflammatory 400mg (6) Retinyl Acetate and Beta-Carotene - antioxidant 3500 IU
(7) Ascorbic Acid - antioxidant 60mg (8) dl-Alpha Tocopheryl Acetate - antioxidant 30 IU
(9) The following ingredients are to help rejeuvenate and heal the skin:
(10) Cholecalciferol 400 IU
(11) Phytonadione 25mcg (12) Thiamin Mononitrate 1.5mg (13) Riboflavin 1.7mg (14) Niacinamide 20mg (15) Pyridoxine Hydrochloride 2mg (16) Folic Acid 400mcg (17) Cyanocobalamin 6mcg (18) d-Biotin 30mcg (19) d-Calcium Pantothenate 10mg (20) Dicalcium Phosphate and calcium carbonate 162mg (21) Ferrous fumarate 18mg (22) Dicalcium Phosphate 109mg (23) Potassium Iodide 150mcg (24) Magnesium Oxide 100mg (25) Zinc Oxide 15mg (26) Sodium Selenate 20mcg (27) Cupric Oxide 2mg (28) Manganese Sulfate 2mg (29) Chromium Chloride 120mcg (30) Sodium Molybdate 75mcg (31) Potassium Chloride 72mg (32) Boron 150mcg (33) Nickel Sulfate 5mcg (34) Silicon Dioxide 2mg (35) Tin Chloride 10mcg (36) Sodium Metavanadate 10mcg (37) Lutein 250mcg (38) Lycopene 300mcg [Para 39] These components combined help kill bacteria and fungus that cause acne, help reduce oil production by the skin, reduce inflammation and repair underlying skin cells. Some of the ingredients can be omitted, or substituted with similar ingredients to achieve the same results.
[Para 40] The cream can also be used to treat inflammatory skin conditions, itching, scarring, scarring caused by acne, and discolorations of the skin.
Claims
What is claimed is:
A cream that reduces oil production by the skin, reduces inflammation, kills bacteria and fungus that cause acne, and repairs the damaged skin cells.
A cream that reduces oil production by the skin, reduces inflammation, kills bacteria and fungus that cause acne, and repairs the damaged skin cells.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19472608 | 2008-06-20 | ||
| US4194726 | 2008-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2637538A1 true CA2637538A1 (en) | 2009-12-20 |
Family
ID=41449628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002637538A Abandoned CA2637538A1 (en) | 2008-06-20 | 2008-07-08 | Dar 1 (dermal acne remover) |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2637538A1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9642877B1 (en) * | 2016-01-06 | 2017-05-09 | Kenneth O. Russell | Method of administration of chromium and magnesium sulfate for treatment of acne |
| CN107427424A (en) * | 2015-01-16 | 2017-12-01 | 纽璀克斯技术公司 | For strengthening the cosmetic composition orally administered of skin barrier |
| US10449130B2 (en) * | 2008-02-11 | 2019-10-22 | Kenneth O. Russell | Method and composition for inhibiting aged skin |
| CN112206192A (en) * | 2020-11-02 | 2021-01-12 | 南京飞天一淼科技服务有限公司 | Deep acne-removing facial cleanser and preparation method thereof |
| CN115089513A (en) * | 2020-11-26 | 2022-09-23 | 徐美铃 | Camellia seed oil extract moisturizing and hydrating cream |
| WO2024146763A1 (en) * | 2023-01-03 | 2024-07-11 | Klose, Thomas | Substance mixture for use in the dermal treatment of a skin disease, in particular an oncological hand-foot syndrome, and method for producing the substance mixture |
-
2008
- 2008-07-08 CA CA002637538A patent/CA2637538A1/en not_active Abandoned
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10449130B2 (en) * | 2008-02-11 | 2019-10-22 | Kenneth O. Russell | Method and composition for inhibiting aged skin |
| CN107427424A (en) * | 2015-01-16 | 2017-12-01 | 纽璀克斯技术公司 | For strengthening the cosmetic composition orally administered of skin barrier |
| CN107427424B (en) * | 2015-01-16 | 2021-02-05 | 纽璀克斯技术公司 | Orally administered cosmetic composition for enhancing skin barrier |
| US9642877B1 (en) * | 2016-01-06 | 2017-05-09 | Kenneth O. Russell | Method of administration of chromium and magnesium sulfate for treatment of acne |
| CN112206192A (en) * | 2020-11-02 | 2021-01-12 | 南京飞天一淼科技服务有限公司 | Deep acne-removing facial cleanser and preparation method thereof |
| CN112206192B (en) * | 2020-11-02 | 2024-02-23 | 深圳市理然化妆品有限公司 | Deep acne-removing facial cleanser and preparation method thereof |
| CN115089513A (en) * | 2020-11-26 | 2022-09-23 | 徐美铃 | Camellia seed oil extract moisturizing and hydrating cream |
| WO2024146763A1 (en) * | 2023-01-03 | 2024-07-11 | Klose, Thomas | Substance mixture for use in the dermal treatment of a skin disease, in particular an oncological hand-foot syndrome, and method for producing the substance mixture |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2637538A1 (en) | Dar 1 (dermal acne remover) | |
| Kotecha | Nutritional anemia in young children with focus on Asia and India | |
| Raimann et al. | Is vitamin C intake too low in dialysis patients? | |
| Batra et al. | The effect of zinc supplementation on the effects of lead on the rat testis | |
| NZ578781A (en) | Improved stability in vitamin and mineral supplements | |
| US10258645B2 (en) | Citrate containing beverage | |
| US20030211172A1 (en) | Composition and method for substantially reducing the deleterious effects of alcohol on the body | |
| AR052837A1 (en) | COMPOSITIONS THAT CONTAIN IRON | |
| US20080075710A1 (en) | Herbal composition for treating hangovers | |
| AR074861A1 (en) | NUTRITIONAL COMPOSITIONS AND SUPPLEMENTS TO IMPROVE EYE HEALTH AND REDUCE THE EYE INFLAMMATORY RESPONSE | |
| US9420819B2 (en) | Nutritional formulation | |
| CA2481071A1 (en) | Manufactured mineral water composition | |
| Takkar et al. | An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia | |
| WO2009128795A1 (en) | Iron and zinc based pharmaceutical formulation for iron deficiency treatment | |
| CA2680502A1 (en) | Benzoyl free formula (bff) acne treatment solution | |
| CA2461614A1 (en) | Mixture of base-containing micronutrient substances | |
| Akhilender Naidu | Vitamin C in human health and disease is still a mystery? An overview | |
| CN102342956A (en) | Composition of vitamin and mineral as well as application thereof in medicine for treating eczema | |
| Korah et al. | Adverse effects and side effects on vitamin therapy: a review | |
| US10342845B1 (en) | Diabetic nutritional composition | |
| US8440241B1 (en) | Alcohol metabolizing assisting supplement | |
| Nascimento et al. | Benefits of the consumption of Brazil nut (Bertholletia excelsa) extract in male reproductive parameters of streptozotocin-induced diabetic rats | |
| Siva et al. | ’Role of iron and copper in diabetics | |
| Moreno et al. | DNA damage induced by sulfite autoxidation catalyzed by copper (II) tetraglycine complexes | |
| Dutra-de-Oliveira et al. | Drinking water as iron carrier for the prevention of iron deficiency anemia: the Brazilian experience |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |